Toujeo is a solution for injection that contains the active substance insulin glargine. It is long-acting human insulin analogue indicated to improve glycaemic control in adults with Type 1 or Type 2 diabetes mellitus. It is available in pre-filled SoloStar and now DoubleStar pens. Toujeo has been granted marketing authorization by the FDA in February 2015; the European Commission in April 2015 and the Ministry of Health, Labor and Welfare (J-MHLW) in Japan, where its approved brand name is Lantus XR in June 2015. Toujeo has now been launched in more than 40 countries. In January 2020, the European Commission approved the expansion of the indication to include the treatment of diabetes in adolescents and children (6 years and older). Toujeo is available in Toujeo SoloSTAR, a disposable prefilled pen which contains 450 units of insulin glargine and requires one third of the injection volume to deliver the same number of insulin units as Lantus SoloSTAR. In the United States, since 2018, Toujeo is also available in a disposable prefilled pen which contains 900 units of insulin glargine. Global Toujeo sales increased from EURO 649 Million in 2016 to EURO 883 Million in 2019. Toujeo sales in 2019 grew by strong performances in Europe and Rest of the World (ROW) regions whereas United States sales decreased, mainly as a result of a decrease in the average net selling price. It is predicted that global Toujeo sales will increase to EURO 1,232 Million in 2025. URL: toujeo-drug-sales-forecast Meta Title: Historical & Estimated Toujeo Sales Keywords: Sanofi Drugs Sales, Toujeo, Toujeo Estimated Sales, Toujeo Drug Sales Forecast, Toujeo Approval, Human Insulin, High Blood Sugar, Insulin Pen, Diabetes Mellitus, Diabetes Drugs Meta Description: Sanofi drug Toujeo is a long-acting analog of human insulin, indicated for the treatment of diabetes mellitus in adults. Title: Toujeo Drug Sales & Forecast Short Description: Sanofi drug Toujeo is a long-acting man-made insulin used to control high blood sugar in adults and children who are 6 years of age and older with diabetes mellitus. It is available in pre-filled SoloStar and now DoubleStar pens. MNG Tracker report title “Toujeo Drug Sales & Forecast” provides historical as well as estimated Toujeo sales in Global, United States, Europe and Rest of the World market. This is single page report which also covered key factors for the growth/decline of the Toujeo sales in Global, United States, Europe and Rest of the World market.
MNG Tracker is a market research company which offer market research reports and database subscription service. Continuous tracking on latest changes in the industry and predict about the emerging needs, challenges and opportunities, is the essential needs for the growth of the business. MNG Tracker is exists for that. MNG Tracker is steadily monitored on the latest happening in the industries, companies and regulatory policies around the world. MNG Tracker is all about market, research and data. We know our clients; who they are, what they see and what they do. MNG Tracker team is fully dedicated to achieve their needs and expectation.
125/5D, Sector 5 Vrindavan Yojna,
Lucknow - 226002, India
Phone:+91 8527886312,
+ 91 7530849871
Email: info@mngtracker.com
FOLLOW USCOPYRIGHT © 2018 MNG Tracker. All Rights Reserved.